“Parkinson's disease”的搜索结果，显示 71-80 项，共有 9963 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... Parkinson's disease (PD) progression in study ... Disease, Lewy Body Disease, and Frontotemporal Degeneration ... Investigating the Genetic and Phenotypic ...

2. 神经科- 临床试验- 妙佑医疗国际

   The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

3. 神经科- 临床试验- 妙佑医疗国际

   The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... disorders such as Parkinson's disease (PD), Parkinson's disease dementia and dementia with Lewy bodies (PDD/DLB), multiple system atrophy (MSA), progressive ...

5. 神经科- 临床试验- 妙佑医疗国际

   Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases ... Parkinson's disease (PD) progression in study ... Disease, Lewy ...

6. 神经科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's ...

7. 神经科- 临床试验- 妙佑医疗国际

   The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

8. 神经科- 临床试验- 妙佑医疗国际

   This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

9. 多系统萎缩- 在 Mayo Clinic 治疗 - 妙佑医疗国际

   Connect with others like you for support and answers to your questions in the Parkinson's Disease support group on Mayo Clinic Connect, a patient community.

10. 神经科- 临床试验- 妙佑医疗国际

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...